RIGEL PHARMACEUTICALS INC Business Operations Contracts & Agreements
12 Contracts & Agreements
- Collaboration Agreements (8 contracts)
- Sales Agreements (1)
- Supply Agreements (2)
- Termination Agreements (1)
- Amendments to Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd., dated October 29, 2018 (Filed With SEC on November 7, 2024)
- Supply Agreement with Kissei Pharmaceutical Co., Ltd., dated September 3, 2024 (Filed With SEC on November 7, 2024)
- Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd., dated September 3, 2024 (Filed With SEC on November 7, 2024)
- Amendment No. 2 to the License and Collaboration Agreement with Eli Lilly and Company, dated March 11, 2024 (Filed With SEC on May 7, 2024)
- Amendment No. 1 to the License and Collaboration Agreement (Filed With SEC on November 7, 2023)
- License and Collaboration Agreement by and between the Company and Eli Lilly and Company, dated February 28, 2021 (Filed With SEC on May 5, 2021)
- Collaboration and License Agreements with Kissei Pharmaceutical Co., Ltd (Filed With SEC on February 28, 2019)
- Supply Agreements with Kissei Pharmaceutical Co., Ltd (Filed With SEC on February 28, 2019)
- AMENDMENT NO. 1 TO SALES AGREEMENT (Filed With SEC on May 30, 2017)
- Termination Agreement (Filed With SEC on August 2, 2011)
- LICENSEAND COLLABORATION AGREEMENT (Filed With SEC on May 4, 2010)
- COLLABORATION AGREEMENT (Filed With SEC on November 14, 2002)
